In an update on our previous posts concerning the first DePuy ASR hip implant case to go to a jury verdict, Kransky vs Depuy, the California jury just ordered DePuy and Johnson & Johnson to pay Mr. Kransky $8.38 Million in damages finding a design defect in the ASR hip device. No punitive damages were part of the award. It is believed that Johnson & Johnson will be appealing the verdict.
It took more than 6 weeks to complete the trial, and many months to prepare this case for trial in the fall and winter of 2012 by the California trial team. Mr. Kransky suffered from very high cobalt and chromium levels, and had good testimony from his hip replacement surgeon documenting significant metalosis caused by his ASR device that resulted in revision. Because this was the first DePuy ASR hip implant trial, the significance of getting a plaintiff’s verdict was critical. This was not a Bellwether case (a case representative of the average case) but rather was a case selected to go first because the claimant from Montana was ill from unrelated renal cancer. The next ASR hip implant trial is scheduled to begin on March 11, 2013 in Cook County, Illinois. That case is Strum vs Depuy, and it certainly will be of interest to see the outcome in it as well. The first Federal MDL trial begins on May 6, 2013 in Ohio. That case is Dorney–Madgitz vs. DePuy.
The verdict was broken down as follows:
$338,136 in damages for medical expenses
$8 million for physical pain and emotional suffering.
Bloomberg News has also reported the following on this trial:
Other Depuy ASR Hip Implant News
Broadspire manages limited reimbursement programs for recalled DePuy and Stryker hip implants—but these benefits are not guaranteed and may impact your legal rights. Consult an attorney before proceeding.
DePuy has announced a second round of ASR hip implant settlements for patients with revision surgeries through January 2015. Learn who qualifies and what this new proposal could mean for you.
DePuy has proposed a major settlement for U.S. patients who underwent revision surgery due to recalled ASR hip implants, potentially offering compensation through base and supplemental award funds.
Federal prosecutors are investigating Johnson & Johnson’s marketing of recalled hip implants amid growing concerns over device failures and the company’s prior legal troubles.
Over 10,000 DePuy ASR hip implant lawsuits have been filed nationwide, with multiple Bellwether trials underway. Learn where cases stand and what this could mean for affected patients.
Get the facts on upcoming DePuy ASR hip implant trials and the status of settlement talks, as legal teams focus on securing justice for thousands of affected patients nationwide.
